Locations:
Search IconSearch
March 28, 2023/Digestive/News

Advanced Practice Provider IBD Fellowship Enters Year Two

The unique program addresses an unmet need and now looks to expand following its successful first year

Digestive tract illustration

Cleveland Clinic’s unique inflammatory bowel disease (IBD) fellowship program for advanced practice providers (APPs) will soon enter its second year, with further expansion on the horizon.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The first of its kind in the country, the IBD APP program was modeled after advanced IBD fellowships for gastroenterologists. These programs feature subspecialty “entrustable professional activities (EPAs),” or competency marks, that providers should be able to perform unsupervised in a clinical setting.

The program addresses an unmet need, says program co-director Jessica Crimaldi, CNP, IBD, since APPs — primarily nurse practitioners and physician assistants — typically train in primary care but then often work in subspecialty settings.

“In those cases the training is usually on the job,” Crimaldi says. “It’s a huge burden on a hiring manager to train a new APP who doesn’t have any subspecialty training. Because APPs are working so much in GI and specifically in IBD, we felt this program would be helpful to bridge that gap in knowledge that you really don’t get in school.”

This new training approach is particularly important now, due to the dramatically shifting scope of IBD care, says program co-director and medical lead Benjamin Cohen, MD.

“The complexity of IBD care is increasing at a rapid rate,” says Dr. Cohen. “We have many new drugs that have been approved in the last two years, so even community practice gastroenterologists have difficulty keeping up to date with evolving IBD care. Plus, if you have an APP who joins the practice, there may not be the mentorship opportunities there that they need to specifically learn IBD.”

Because the training qualifies APPs for autonomous practice, they can potentially fill a workforce need. “The program provides us the opportunity to help train high-quality APPs to go out and do IBD care in the community,” explains Dr. Cohen. “There’s a big focus on trying to get IBD patients to expert centers, but the reality is the expert centers can’t care for all the IBD patients. There are too many, and people are located in places where they may not have easy access. So it’s really important to have fellowships or other educational programs specifically for APPs to serve those communities.”

Advertisement

The training: GI basics, plus entrustable activities

Thus far the program has one fellow who has nearly completed her year. The first quarter of the training focused on general gastroenterology, followed by IBD-specific content the rest of the year. About a third of the fellow’s time is dedicated to working on a quality or research project, with Dr. Cohen, Crimaldi and other mentors.

The content, derived from the EPAs, includes both outpatient and inpatient direct care of patients with IBD, exposure to IBD endoscopy and surgery, and care of the patient with ileal pouch anal anastomosis. Other aspects include transitions of care, clinical trials and attendance at national IBD conferences.

The fellow participates as part of Cleveland Clinic’s multidisciplinary IBD team, which also includes specialists from rheumatology, dermatology, pathology, radiology, surgery, psychosocial care and nutrition. This is important because patients with IBD also commonly have other chronic medical conditions, Dr. Cohen says.

“At Cleveland Clinic we have an IBD medical home. We explain to patients that we have team-based care. It’s really about approaching their disease from multiple angles to improve their outcomes.”

Next steps: Adding another fellow, new models

Another fellow will be added to the program in the coming months, and possibly another after that in less than a year’s time. “The first year has been very successful. Now, we’re looking at different models for how to include more people, whether it’s the one-year fellowships or doing shorter fellowships or preceptorships and having more fellows working in the community,” Dr. Cohen says.

Advertisement

An entire year may not be necessary, depending on the APP’s goals. “Some might want to become an expert clinician and primarily take care of patients, while others might want to learn about research and develop a more academic career, which is something we can offer as well. The nice thing about a program like this is that we can really tailor it to the need of the fellow we’re training,” Dr. Cohen observes.

Crimaldi points out that this IBD fellowship adds to Cleveland Clinic’s portfolio of APP fellowships going back about a decade, including similar programs in dermatology and emergency medicine with more planned for the future. “At Cleveland Clinic there’s a big focus on training and orientation for APPs,” she notes.

Dr. Cohen agrees, “Because of that precedent, it seemed natural to extend this to IBD because we are one of the international leaders in IBD education.”

Advertisement

Related Articles

Doctor speaking with patient
October 29, 2024/Digestive/Research
RSV Vaccination Lowers Risk for IBD Patients Over 60, Study Finds

Despite benefits, vaccination rates remain low for high-risk population

Young woman talking with others in a circle
Roundtable Convenes to Improve Outcomes for Young Adults With IBD

Patients, caregivers and healthcare partners explore challenges during key transition points in care

Patient taking medication
May 22, 2024/Digestive/Research
Study Finds No Connection Between OSMs and Increased Cancer Rates in IBD Patients

Reassuring results, but patient education is still important

OCT scan showing dry AMD
Autoimmune Disease Linked With Higher Risk of Macular Degeneration

Early data show risk is 73% higher in patients with lupus, 40% higher in patients with rheumatoid arthritis

Loop ileostomy
July 14, 2023/Digestive/Research
Comparing Treatment Strategies for High-Risk Ileocolic Crohn’s Disease

Findings from a 2023 ASCRS presentation indicate that both 2-stage and modified 2-stage approaches are viable management strategies for Crohn’s patients who require a temporary ileostomy

Ad